Winter Park, FL, United States of America

Kiminobu Sugaya

This inventor holds 29 USPTO granted patents and 17 published patent applications, plus 4 CIPO patents and 3 EPO patents, primarily in Stem Cell Technology. Top assignees: University of Central Florida Research Foundation Inc., University of Illinois, Institute for Scientific Research and Technology Services (Indicasat). Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kiminobu Sugaya. Retrieved from https://idiyas.com/inventor/kiminobu-sugaya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 17)

% Patents Active = 62.1

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 8)

Average Co-Inventor Count = 2.3

ph-index = 6

Forward Citations = 186(Granted Patents)

Location History:

Willow Springs, IL (US) (2009 - 2012)
Oviedo, FL (US) (2012 - 2013)
Winter Park, FL (US) (2011 - 2017)
Orlando, FL (US) (2015 - 2021)

Company Filing History:

24 out of 1,374

University of Central Florida Research Foundation Inc.

patents

5 out of 2,430

University of Illinois

patents

1 out of 1

Institute for Scientific Research and Technology Services (Indicasat)

patent

where one patent can have more than one assignee

Years Active: 2009-2026

Loading Chart...

Areas of Expertise:

Mesenchymal Stem Cells

Neurogenesis

Cancer Diagnostics

Cell Potency

Retinal Development

Stem Cell Migration

Image Tracking

Tissue Substitutes

Multipotent Stem Cells

Cellular Development

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12577532 - Xeno-free and transgene-free reprograming of mesenchymal stem cells toward neural progenitor cells (2026-03-17),

2. 11193174 - Exosomal NANOG DNA as a diagnostic cancer marker (2021-12-07),

3. 10751340 - Combination therapy to improve brain function or promote neurogenesis for treating neurodegenerative conditions (2020-08-25),

4. 9791938 - System and methods of camera-based fingertip tracking (2017-10-17),

5. 9506031 - Methods and materials for increasing potency of cells (2016-11-29),

6. 9358234 - Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof (2016-06-07),

7. 9243226 - Biasing of cells toward retinal, corneal or lens development (2016-01-26),

8. 9127291 - Methods and products for biasing cellular development (2015-09-08),

9. 9095573 - Method of biasing implanted human neural stem cells away from differentiation into glial cells by (+)phenserine to modulate the concentration of soluble βAPP in tissue or CSF (2015-08-04),

10. 9084789 - Use of modified pyrimidine compounds to promote stem cell migration and proliferation (2015-07-21),

11. 9001036 - Systems and methods of camera-based fingertip tracking (2015-04-07),

12. 8906683 - Methods and materials for increasing potency of cells (2014-12-09),

13. 8791128 - Compositions for treating or delaying the onset of hair loss (2014-07-29),

14. 8774560 - System for manipulation, modification and editing of images via remote device (2014-07-08),

15. 8759090 - Stem cell banking system (2014-06-24),

Title: Kiminobu Sugaya: Pioneering Innovations in Cancer Diagnosis and Neurodegenerative Treatments

Introduction

Kiminobu Sugaya is a renowned inventor based in Winter Park, FL, who has made significant contributions to the fields of cancer diagnostics and neurodegeneration. With a remarkable portfolio of 28 patents, Sugaya's inventions are at the forefront of medical innovation, demonstrating his expertise and dedication to improving patient outcomes.

Latest Patents

One of Sugaya's latest patents focuses on using exosomal NANOG DNA as a diagnostic cancer marker. This patent provides methods for detecting cancer through the analysis of DNA within extracellular vesicles. The process involves obtaining a biological sample from a patient, isolating the vesicles, detecting the amount of NANOG DNA present, and comparing it with levels from non-cancer cell samples to indicate cancer presence.

Another significant patent involves a combination therapy aimed at enhancing brain function and promoting neurogenesis in patients suffering from neurodegenerative conditions. This method includes the co-administration of phenserine and NBI-18, which are strategically combined to improve brain functionality or induce neurogenesis in affected patients.

Career Highlights

Kiminobu Sugaya has had a distinguished career, working with reputable institutions like the University of Central Florida Research Foundation and the University of Illinois. His work at these institutions has enabled him to explore various innovative approaches to some of the most pressing health issues today.

Collaborations

Throughout his career, Sugaya has collaborated with notable colleagues such as Angel Alvarez and Tingyu Qu. These partnerships have facilitated the development of groundbreaking methods that address complex medical challenges.

Conclusion

Kiminobu Sugaya's contributions to the medical field through his 28 patents showcase his innovative spirit and commitment to advancing healthcare. His work in cancer diagnostics and neurodegenerative treatments continues to inspire future research and innovation, making significant strides towards better patient care.

Profile summary based on public USPTO records.